Isokinetic microdose exercise for women with fibromyalgia
Official title: Effects of a Microdoses Isokinetic Exercise Protocol in Women With Fibromyalgia
Run by European University Miguel de Cervantes · NCT07483216 · Data updated 2026-11-12
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 36 (estimated) |
| Sponsor | European University Miguel de Cervantes Academic / other |
| Locations | 1 site (Valladolid, Valladolid) |
| Status | Recruiting |
| Started | April 2026 |
| Main results expected | July 2026 |
| Study ends | July 2026 |
| Registry record updated | April 16, 2026 |
| Trial ID | NCT07483216 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women diagnosed with fibromyalgia who are clinically and pharmacologically stable and able to perform supervised exercise sessions are the ideal candidates.
✕Probably not a fit
Men, people with unstable medical conditions or cardiovascular/neurologic/musculoskeletal contraindications to exercise, or those unable to attend supervised sessions are unlikely to receive benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study enrolls adult women with a clinical diagnosis of fibromyalgia to receive an 8-week supervised isokinetic exercise program delivered using microdosing principles to limit intensity and volume. Isokinetic equipment will control movement velocity and joint position to enable safe, precisely dosed muscle contractions. Researchers will measure physical condition (including strength and function), perceived pain, inflammatory biomarkers, and quality of life before and after the intervention. Participants must be clinically and pharmacologically stable and able to attend supervised sessions at the study site.
Why it matters
Potential benefit: If successful, this approach could provide a low-intensity, better-tolerated exercise option that reduces pain and improves strength and daily functioning for women with fibromyalgia.
How similar studies have gone: General exercise programs have demonstrated benefits in fibromyalgia, but isokinetic microdosing is a relatively novel approach with limited prior clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged ≥ 18 years diagnosed with fibromyalgia according to current clinical criteria. * Clinical and pharmacological stability during the weeks prior to participation in the study. * Ability to perform supervised exercise and to complete the assessments. * Written informed consent. Exclusion Criteria: * Cardiovascular, neurologic, musculoskeletal or systemic pathology that contraindicate the performance of exercise. * Significant change in pharmacological treatment during the period immediately preceding the study. * Any condition that, in clinical judgement, prevents them from following the protocol safely.
Where it's running
-
Miguel de Cervantes European University
Valladolid, Valladolid, Spain Recruiting
Study contacts
- Principal investigator: Alejandro Santos Lozano, PhD — Miguel de Cervantes European University
- Study coordinator: Alejandro Santos Lozano, PhD
- Email: asantos@uemc.es
- Phone: 0034983001000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Dietary strategies to help fibromyalgia in overweight or obese women
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
-
Does hardaliye help fibromyalgia when added to a personalized diet?
This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.
-
Personalized ultrasonic brain stimulation to reduce fibromyalgia symptoms
This study will test whether personalized low-intensity ultrasound to the brain can reduce pain and other symptoms in adults with fibromyalgia who have not improved after standard medications and physical therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.